Literature DB >> 25952741

⁹⁰Y Hepatic Radioembolization: An Update on Current Practice and Recent Developments.

Arthur J A T Braat1, Maarten L J Smits2, Manon N G J A Braat1, Andor F van den Hoven2, Jip F Prince2, Hugo W A M de Jong2, Maurice A A J van den Bosch2, Marnix G E H Lam2.   

Abstract

Radioembolization is an established treatment modality that has been subjected to many improvements over the last decade. Developments are occurring at a high pace, affecting patient selection and treatment. The aim of this review is therefore to provide an overview of current practice, with a focus on recent developments in the field of radioembolization. Several practical issues and recommendations in the application of radioembolization will be discussed, ranging from patient selection to treatment response and future applications.
© 2015 by the Society of Nuclear Medicine and Molecular Imaging, Inc.

Entities:  

Keywords:  90Y; dosimetry; hepatic vasculature; liver malignancies; radioembolization

Mesh:

Substances:

Year:  2015        PMID: 25952741     DOI: 10.2967/jnumed.115.157446

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  24 in total

1.  A Pilot Study on Hepatobiliary Scintigraphy to Monitor Regional Liver Function in 90Y Radioembolization.

Authors:  Sandra van der Velden; Manon N G J A Braat; Tim A Labeur; Mike V Scholten; Otto M van Delden; Roelof J Bennink; Hugo W A M de Jong; Marnix G E H Lam
Journal:  J Nucl Med       Date:  2019-04-06       Impact factor: 10.057

2.  Nuclear Theranostics in Taiwan.

Authors:  Ko-Han Lin; Yi-Wei Chen; Rheun-Chuan Lee; Ling-Wei Wang; Fong-In Chou; Chi-Wei Chang; Sang-Hue Yen; Wen-Sheng Huang
Journal:  Nucl Med Mol Imaging       Date:  2019-02-01

3.  Personalized Dosimetry for Liver Cancer Y-90 Radioembolization Using Computational Fluid Dynamics and Monte Carlo Simulation.

Authors:  Emilie Roncali; Amirtahà Taebi; Cameron Foster; Catherine Tram Vu
Journal:  Ann Biomed Eng       Date:  2020-01-31       Impact factor: 3.934

4.  Feasibility of imaging 90 Y microspheres at diagnostic activity levels for hepatic radioembolization treatment planning.

Authors:  Britt Kunnen; Martijn M A Dietze; Arthur J A T Braat; Marnix G E H Lam; Max A Viergever; Hugo W A M de Jong
Journal:  Med Phys       Date:  2020-01-20       Impact factor: 4.071

Review 5.  Targeted Radionuclide Therapy: An Evolution Toward Precision Cancer Treatment.

Authors:  Hossein Jadvar
Journal:  AJR Am J Roentgenol       Date:  2017-05-02       Impact factor: 3.959

6.  A MAA-based dosimetric study in patients with intrahepatic cholangiocarcinoma treated with a combination of chemotherapy and 90Y-loaded glass microsphere selective internal radiation therapy.

Authors:  Vincent Manceau; Xavier Palard; Yan Rolland; March Pracht; Samuel Le Sourd; Sophie Laffont; Karim Boudjema; Astride Lievre; Habiba Mesbah; Laure-Anne Haumont; Laurence Lenoir; Vanessa Brun; Thomas Uguen; Julien Edeline; Etienne Garin
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-03-20       Impact factor: 9.236

7.  Combined sorafenib and yttrium-90 radioembolization for the treatment of advanced hepatocellular carcinoma.

Authors:  A Salman; E Simoneau; M Hassanain; P Chaudhury; L M Boucher; D Valenti; T Cabrera; C Nudo; P Metrakos
Journal:  Curr Oncol       Date:  2016-10-25       Impact factor: 3.677

8.  Lung Dose Measured on Postradioembolization 90Y PET/CT and Incidence of Radiation Pneumonitis.

Authors:  Martina Stella; Rob van Rooij; Marnix G E H Lam; Hugo W A M de Jong; Arthur J A T Braat
Journal:  J Nucl Med       Date:  2021-11-12       Impact factor: 11.082

9.  Treating hepatocellular carcinoma with 90Y-bearing microspheres: a review.

Authors:  Te-Chun Hsieh; Yu-Chin Wu; Shung-Shung Sun; Kuo-Yang Yen; Chia-Hung Kao
Journal:  Biomedicine (Taipei)       Date:  2016-11-16

Review 10.  Microspheres Used in Liver Radioembolization: From Conception to Clinical Effects.

Authors:  Philippe d'Abadie; Michel Hesse; Amandine Louppe; Renaud Lhommel; Stephan Walrand; Francois Jamar
Journal:  Molecules       Date:  2021-06-29       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.